Pharmaceuticals / Job Losses
Novo Nordisk to Cut 9,000 Jobs Amid Increased Competition
Novo Nordisk, the Danish manufacturer of popular weight-loss and diabetes drugs Ozempic and Wegovy, has announced it will cut 9,000 jobs globally due to increased competition from US rival Eli Lilly and disappointing clinical trial results....